Generic Lunesta Now Available

Mylan announced it has received final approval from the FDA for its Abbreviated New Drug Application (ANDA) of Eszopiclone Tablets, the generic version of Sunovion's Lunesta.

Lunesta is a non-benzodiazepine pyrrolopyrazine hypnotic indicated for the treatment of insomnia (decreased sleep latency and improved sleep maintenance). Its effect is believed to result from its interaction with GABA-receptor complexes at binding domains located close to or allosterically coupled to benzodiazepine receptors.

RELATED: Psychiatric Disorders Resource Center

Eszopiclone Tablets are available in 1mg, 2mg, and 3mg strength tablets.

For more information call (800) RX-MYLAN or visit